Live from the NIH registry
Studies recruiting near Colorado Springs right now
Top 25 of 207 recruiting studies, sorted by proximity — each links to its official registry page
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Colorado Springs, Colorado (4.0 mi)
· Sponsor: AstraZeneca
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Ulcerative Colitis
Phase 2
Interventional 80 participants sought
Peak Gastroenterology Associates — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Boehringer Ingelheim
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
Peak Gastroenterology Associates — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Eli Lilly and Company
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
UC Health Oncology Research — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Hoffmann-La Roche
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Rocky Mountain Cancer Centers-Penrose — Colorado Springs, Colorado (4.0 mi)
· Sponsor: NRG Oncology
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
Neuroblastoma Recurrent
Phase 2
Interventional 54 participants sought
Children's Hospital of Colorado — Colorado Springs, Colorado (4.0 mi)
· Sponsor: St. Jude Children's Research Hospital
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Malignancy
N/A
Observational 240 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Primary Open Angle Glaucoma
Phase 3
Interventional 130 participants sought
Colorado Eye Institute /ID# 277072 — Colorado Springs, Colorado (4.0 mi)
· Sponsor: AbbVie
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Phase 3
Interventional 255 participants sought
UCHealth Memorial Hospital Central — Colorado Springs, Colorado (4.0 mi)
· Sponsor: National Cancer Institute (NCI)
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Medtronic
Improving Care for Rural Patients With Solid Tumors
Lung Cancer, Head and Neck Cancer
N/A
Interventional 320 participants sought
Memorial Hospital Central — Colorado Springs, Colorado (4.0 mi)
· Sponsor: University of Colorado, Denver
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Non-Small Cell Lung Cancer, NSCLC, KRAS, NRAS, HRAS-mutated NSCLC
Phase 1, Phase 2
Interventional 616 participants sought
Colorado Health Medical Group - Medical Oncology & Hematology — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Revolution Medicines, Inc.
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8
Phase 3
Interventional 474 participants sought
Rocky Mountain Cancer Centers-Penrose — Colorado Springs, Colorado (4.0 mi)
· Sponsor: NRG Oncology
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Metabolic Dysfunction Associated Steatohepatitis
Phase 3
Interventional 1,590 participants sought
Future Innovative Treatments — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Boehringer Ingelheim
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos
N/A
Interventional 535 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Rocky Mountain Cancer Centers-Penrose — Colorado Springs, Colorado (4.0 mi)
· Sponsor: NRG Oncology
VTP-1000 in Adults With Celiac Disease
Celiac Disease
EARLY/Phase 1
Interventional 45 participants sought
Peak Gastroenterology Associates — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Barinthus Biotherapeutics
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Idiopathic Hypersomnia
Phase 3
Interventional 248 participants sought
Delta Waves LLC — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Harmony Biosciences Management, Inc.
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
Retina Consultants of Southern Colorado — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 425 participants sought
Peak Gastroenterology Associates — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Hoffmann-La Roche
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Colorado Springs, Colorado (4.0 mi)
· Sponsor: 89bio, Inc.